News

The multi-center study is being conducted by Inovio’s clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080. Earlier, Inovio reported

AMP said that the new high volume vial filling line is a 8 head Conquest line with a capacity of 150,000 vials per shift and is supported by

Zynex, a provider of pain management systems and electrotherapy medical devices, said that a provisional patent has been filed for the application, which could serve a currently untapped

The AQT90 Flex helps emergency departments to ensure a fast and accurate process for ruling in/out acute myocardial infarction (AMI) patients avoiding consuming procedures. According to European Society

Tacrolimus capsules is an immunosuppressant. It blocks the action of certain blood cells (eg, T lymphocytes) that can cause the body to reject the transplanted organ. Mylan Pharma’s

Kinetic Systems has added Maris to its board of directors and he is also expected to continue to oversee the International Operations division. Maris has been with Kinetics

The filing triggers a milestone payment to Lausanne, Switzerland-based drug delivery company EffRx. Nycomed and EffRx entered into the licensing agreement for EX101 in early 2009 and Nycomed

The company intends to introduce Synvisc in Japan by the end of this year. Further, Genzyme has provided exclusive commercialisation rights to Teijin Pharma for Synvisc in Japan,

Biomagnetics Diagnostics has signed the formal merger agreement and all necessary governmental approvals are expected to be completed mid-week. Biomagnetics CEO Clayton Hardman said that they have selected